Antios scores $25 mln Series A
Antios Therapeutics Inc, a biopharmaceutical company, has secured $25 million in Series A financing. Lumira Ventures and Domain Associates led the round.
27 November 2018•1 min read
Antios Therapeutics Inc, a biopharmaceutical company, has secured $25 million in Series A financing. Lumira Ventures and Domain Associates led the round.
